← Evidence map

ArticleMolecular oncology2026

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA-PKcs/CHK1 replicative checkpoint to inhibit cell growth in non-small cell lung cancer.

Amani Shreim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA-PKcs/CHK1 replicative checkpoint to inhibit cell growth in non-small cell lung cancer. | Socratic